Concepts (280)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trypanosoma cruzi | 33 | 2022 | 154 | 4.740 |
Why?
|
| Chagas Disease | 19 | 2022 | 101 | 2.980 |
Why?
|
| Protozoan Proteins | 10 | 2020 | 196 | 1.180 |
Why?
|
| Trypanocidal Agents | 6 | 2019 | 39 | 1.070 |
Why?
|
| Oxadiazoles | 3 | 2015 | 15 | 0.950 |
Why?
|
| Imidazoles | 5 | 2018 | 138 | 0.800 |
Why?
|
| Cytochrome P-450 Enzyme System | 6 | 2015 | 99 | 0.710 |
Why?
|
| Thrombospondin 1 | 4 | 2022 | 23 | 0.680 |
Why?
|
| alpha-Defensins | 2 | 2013 | 22 | 0.670 |
Why?
|
| Drug Discovery | 2 | 2019 | 106 | 0.590 |
Why?
|
| Antiprotozoal Agents | 3 | 2018 | 33 | 0.550 |
Why?
|
| RNA Interference | 3 | 2010 | 246 | 0.520 |
Why?
|
| Coronary Vessels | 2 | 2010 | 92 | 0.520 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2010 | 92 | 0.510 |
Why?
|
| RNA, Small Interfering | 3 | 2021 | 436 | 0.490 |
Why?
|
| Epithelial Cells | 3 | 2018 | 426 | 0.490 |
Why?
|
| Animals | 34 | 2022 | 16694 | 0.480 |
Why?
|
| Leishmaniasis, Visceral | 1 | 2015 | 17 | 0.460 |
Why?
|
| Benzamides | 2 | 2015 | 78 | 0.460 |
Why?
|
| Cocaine | 4 | 2020 | 248 | 0.450 |
Why?
|
| Enzyme Inhibitors | 4 | 2013 | 457 | 0.430 |
Why?
|
| Flagella | 1 | 2013 | 31 | 0.400 |
Why?
|
| Host-Parasite Interactions | 3 | 2009 | 75 | 0.400 |
Why?
|
| Laminin | 2 | 2006 | 58 | 0.400 |
Why?
|
| Locomotion | 1 | 2013 | 104 | 0.380 |
Why?
|
| Defensins | 1 | 2010 | 5 | 0.340 |
Why?
|
| Receptors, Cell Surface | 2 | 2009 | 146 | 0.330 |
Why?
|
| Gene Regulatory Networks | 2 | 2016 | 143 | 0.320 |
Why?
|
| Trypanosoma brucei brucei | 4 | 2014 | 82 | 0.320 |
Why?
|
| Casein Kinase II | 2 | 2008 | 16 | 0.320 |
Why?
|
| Humans | 37 | 2021 | 42113 | 0.320 |
Why?
|
| Mice | 16 | 2022 | 6490 | 0.320 |
Why?
|
| Drug Design | 5 | 2018 | 183 | 0.310 |
Why?
|
| MicroRNAs | 3 | 2020 | 501 | 0.300 |
Why?
|
| Mice, Inbred BALB C | 5 | 2015 | 686 | 0.290 |
Why?
|
| Endothelial Cells | 3 | 2022 | 324 | 0.280 |
Why?
|
| HIV-1 | 5 | 2020 | 747 | 0.280 |
Why?
|
| Aspergillus fumigatus | 2 | 2018 | 13 | 0.280 |
Why?
|
| Variant Surface Glycoproteins, Trypanosoma | 2 | 2014 | 8 | 0.270 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2019 | 167 | 0.270 |
Why?
|
| DNA Fragmentation | 1 | 2007 | 95 | 0.260 |
Why?
|
| Ligands | 7 | 2021 | 387 | 0.260 |
Why?
|
| Galectin 3 | 2 | 2004 | 29 | 0.260 |
Why?
|
| Cloning, Molecular | 2 | 2012 | 318 | 0.260 |
Why?
|
| Myoblasts, Cardiac | 1 | 2006 | 4 | 0.250 |
Why?
|
| Trypanosomiasis | 2 | 2007 | 2 | 0.250 |
Why?
|
| Cell Membrane | 4 | 2013 | 400 | 0.240 |
Why?
|
| Antifungal Agents | 4 | 2018 | 169 | 0.240 |
Why?
|
| Antigens, Protozoan | 2 | 2006 | 74 | 0.230 |
Why?
|
| Gene Silencing | 1 | 2006 | 154 | 0.230 |
Why?
|
| Dopamine Uptake Inhibitors | 2 | 2017 | 81 | 0.230 |
Why?
|
| Active Transport, Cell Nucleus | 3 | 2022 | 60 | 0.230 |
Why?
|
| Mucins | 2 | 2002 | 69 | 0.210 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2004 | 142 | 0.200 |
Why?
|
| 3' Untranslated Regions | 2 | 2020 | 81 | 0.200 |
Why?
|
| Membrane Proteins | 1 | 2006 | 548 | 0.190 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 1554 | 0.190 |
Why?
|
| Naegleria fowleri | 1 | 2021 | 2 | 0.180 |
Why?
|
| Cell Fusion | 1 | 2001 | 19 | 0.180 |
Why?
|
| Neuraminidase | 3 | 2008 | 9 | 0.180 |
Why?
|
| Myocardium | 2 | 2020 | 250 | 0.180 |
Why?
|
| Substrate Specificity | 6 | 2021 | 217 | 0.180 |
Why?
|
| beta Catenin | 1 | 2022 | 75 | 0.170 |
Why?
|
| Rats | 5 | 2022 | 3701 | 0.170 |
Why?
|
| Proline | 1 | 2021 | 39 | 0.170 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2019 | 122 | 0.170 |
Why?
|
| Myoblasts | 1 | 2020 | 30 | 0.160 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2021 | 69 | 0.160 |
Why?
|
| Antigens, Differentiation | 1 | 2000 | 23 | 0.160 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2020 | 20 | 0.160 |
Why?
|
| Glutamic Acid | 1 | 2021 | 131 | 0.160 |
Why?
|
| Myocytes, Cardiac | 3 | 2020 | 173 | 0.160 |
Why?
|
| Candida albicans | 2 | 2018 | 173 | 0.160 |
Why?
|
| Capsid | 1 | 2020 | 64 | 0.150 |
Why?
|
| Nucleus Accumbens | 1 | 2020 | 99 | 0.150 |
Why?
|
| Homeostasis | 1 | 2021 | 191 | 0.150 |
Why?
|
| Molecular Structure | 4 | 2015 | 560 | 0.150 |
Why?
|
| Triazoles | 4 | 2017 | 100 | 0.150 |
Why?
|
| Extracellular Matrix | 1 | 2000 | 129 | 0.150 |
Why?
|
| Nitroimidazoles | 1 | 2019 | 10 | 0.150 |
Why?
|
| Sterols | 4 | 2012 | 23 | 0.150 |
Why?
|
| Dipeptidases | 1 | 2019 | 9 | 0.150 |
Why?
|
| Tetrazoles | 2 | 2017 | 45 | 0.150 |
Why?
|
| Microvessels | 1 | 2019 | 31 | 0.150 |
Why?
|
| Methamphetamine | 1 | 2021 | 166 | 0.150 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 303 | 0.150 |
Why?
|
| Virus Release | 2 | 2016 | 8 | 0.150 |
Why?
|
| Pyridines | 2 | 2017 | 134 | 0.140 |
Why?
|
| Artificial Intelligence | 1 | 2019 | 94 | 0.140 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 1066 | 0.140 |
Why?
|
| Amino Acid Sequence | 3 | 2010 | 1188 | 0.140 |
Why?
|
| Drugs, Investigational | 1 | 2017 | 1 | 0.130 |
Why?
|
| Colon | 1 | 2018 | 118 | 0.130 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 167 | 0.130 |
Why?
|
| Cells, Cultured | 4 | 2018 | 1617 | 0.130 |
Why?
|
| Protein Binding | 5 | 2017 | 1076 | 0.130 |
Why?
|
| Proteome | 1 | 2018 | 150 | 0.130 |
Why?
|
| Cell Adhesion | 3 | 2004 | 237 | 0.130 |
Why?
|
| Phosphoproteins | 1 | 2018 | 201 | 0.130 |
Why?
|
| Crystallography, X-Ray | 5 | 2018 | 285 | 0.130 |
Why?
|
| Protein Conformation | 5 | 2018 | 420 | 0.120 |
Why?
|
| Human Immunodeficiency Virus Proteins | 1 | 2016 | 4 | 0.120 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2016 | 8 | 0.120 |
Why?
|
| Chagas Cardiomyopathy | 1 | 2016 | 8 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2021 | 467 | 0.120 |
Why?
|
| Proline Oxidase | 1 | 2015 | 11 | 0.120 |
Why?
|
| Molecular Sequence Data | 2 | 2010 | 1559 | 0.120 |
Why?
|
| Minority Groups | 1 | 2021 | 663 | 0.120 |
Why?
|
| Antigens, CD | 1 | 2016 | 122 | 0.120 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2015 | 52 | 0.120 |
Why?
|
| Models, Molecular | 5 | 2018 | 875 | 0.110 |
Why?
|
| Biotransformation | 1 | 2015 | 68 | 0.110 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2015 | 98 | 0.110 |
Why?
|
| Ergosterol | 1 | 2014 | 12 | 0.110 |
Why?
|
| Microsomes, Liver | 1 | 2015 | 71 | 0.110 |
Why?
|
| Binding Sites | 3 | 2020 | 670 | 0.110 |
Why?
|
| Tissue Distribution | 1 | 2015 | 230 | 0.110 |
Why?
|
| Carbamates | 1 | 2014 | 13 | 0.110 |
Why?
|
| Adenoviridae | 1 | 2014 | 62 | 0.110 |
Why?
|
| Glycoproteins | 2 | 2008 | 127 | 0.110 |
Why?
|
| Autophagy | 1 | 2015 | 136 | 0.110 |
Why?
|
| Genetic Vectors | 1 | 2014 | 165 | 0.100 |
Why?
|
| Capsid Proteins | 1 | 2014 | 74 | 0.100 |
Why?
|
| HCT116 Cells | 1 | 2013 | 40 | 0.100 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 491 | 0.100 |
Why?
|
| Molecular Weight | 2 | 2006 | 168 | 0.100 |
Why?
|
| Cocaine-Related Disorders | 1 | 2014 | 99 | 0.100 |
Why?
|
| HIV Infections | 2 | 2020 | 2535 | 0.100 |
Why?
|
| Macrophages | 3 | 2003 | 515 | 0.100 |
Why?
|
| Adaptor Protein Complex 3 | 1 | 2012 | 1 | 0.100 |
Why?
|
| Adaptor Protein Complex delta Subunits | 1 | 2012 | 1 | 0.100 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 18 | 0.100 |
Why?
|
| Calreticulin | 1 | 2012 | 8 | 0.100 |
Why?
|
| Monocytes | 2 | 2019 | 275 | 0.090 |
Why?
|
| Neurons | 2 | 2021 | 1246 | 0.090 |
Why?
|
| Hermanski-Pudlak Syndrome | 1 | 2012 | 16 | 0.090 |
Why?
|
| Virus Assembly | 1 | 2012 | 44 | 0.090 |
Why?
|
| Administration, Oral | 1 | 2013 | 256 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2013 | 362 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 276 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2015 | 534 | 0.090 |
Why?
|
| Hela Cells | 2 | 2016 | 370 | 0.090 |
Why?
|
| Mutation | 4 | 2020 | 1169 | 0.090 |
Why?
|
| Signal Transduction | 4 | 2020 | 2111 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 683 | 0.080 |
Why?
|
| Apoptosis | 2 | 2017 | 1541 | 0.080 |
Why?
|
| Trypanosomiasis, African | 1 | 2009 | 22 | 0.080 |
Why?
|
| Immunoprecipitation | 2 | 2012 | 128 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2013 | 541 | 0.080 |
Why?
|
| Indomethacin | 1 | 2009 | 26 | 0.080 |
Why?
|
| Brain | 1 | 2017 | 1449 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 2 | 2002 | 301 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 310 | 0.070 |
Why?
|
| Trypanosoma | 1 | 2008 | 8 | 0.070 |
Why?
|
| Fibronectins | 1 | 1989 | 69 | 0.070 |
Why?
|
| Phagocytosis | 1 | 1989 | 83 | 0.070 |
Why?
|
| Amides | 1 | 2009 | 72 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2013 | 1582 | 0.070 |
Why?
|
| Nuclear Localization Signals | 1 | 2008 | 14 | 0.070 |
Why?
|
| Serine Endopeptidases | 1 | 2008 | 48 | 0.070 |
Why?
|
| Cysteine Endopeptidases | 1 | 2008 | 64 | 0.070 |
Why?
|
| Response Elements | 1 | 2008 | 55 | 0.070 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2007 | 35 | 0.070 |
Why?
|
| Vacuoles | 1 | 2007 | 22 | 0.070 |
Why?
|
| Female | 4 | 2015 | 23980 | 0.070 |
Why?
|
| Oxidoreductases | 1 | 2007 | 79 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2008 | 173 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 599 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 160 | 0.060 |
Why?
|
| Immunoblotting | 2 | 2010 | 181 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2007 | 154 | 0.060 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2008 | 89 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 2598 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2006 | 973 | 0.060 |
Why?
|
| Fibroblasts | 2 | 2012 | 278 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2008 | 383 | 0.060 |
Why?
|
| Epidermal Growth Factor | 2 | 2003 | 69 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 1804 | 0.060 |
Why?
|
| Virulence Factors | 1 | 2006 | 119 | 0.060 |
Why?
|
| Microsomes | 2 | 2018 | 55 | 0.060 |
Why?
|
| Catalytic Domain | 2 | 2018 | 118 | 0.060 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2003 | 18 | 0.050 |
Why?
|
| Transfection | 1 | 2004 | 526 | 0.050 |
Why?
|
| Methyltransferases | 2 | 2014 | 66 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2017 | 232 | 0.050 |
Why?
|
| Male | 5 | 2021 | 22745 | 0.050 |
Why?
|
| Hybridomas | 1 | 2002 | 24 | 0.050 |
Why?
|
| Immunoglobulin Fragments | 1 | 2002 | 12 | 0.050 |
Why?
|
| Endothelium | 1 | 2022 | 28 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2008 | 990 | 0.050 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2001 | 13 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 198 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 2001 | 55 | 0.040 |
Why?
|
| Muscles | 1 | 2001 | 84 | 0.040 |
Why?
|
| Epitopes | 1 | 2002 | 155 | 0.040 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2021 | 16 | 0.040 |
Why?
|
| Maryland | 1 | 2021 | 61 | 0.040 |
Why?
|
| Cricetulus | 1 | 2021 | 82 | 0.040 |
Why?
|
| Cell Line | 1 | 2004 | 1416 | 0.040 |
Why?
|
| CHO Cells | 1 | 2021 | 123 | 0.040 |
Why?
|
| Acute Disease | 1 | 2021 | 156 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2020 | 58 | 0.040 |
Why?
|
| Communicable Diseases | 1 | 2021 | 47 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 456 | 0.040 |
Why?
|
| Lactose | 1 | 2000 | 16 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 54 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 2000 | 51 | 0.040 |
Why?
|
| Heart | 1 | 2022 | 181 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2000 | 86 | 0.040 |
Why?
|
| Models, Animal | 1 | 2020 | 149 | 0.040 |
Why?
|
| Azoles | 2 | 2011 | 12 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 188 | 0.040 |
Why?
|
| Virus Integration | 1 | 2020 | 65 | 0.040 |
Why?
|
| Research Personnel | 1 | 2021 | 191 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2020 | 190 | 0.040 |
Why?
|
| Collagen | 1 | 2000 | 178 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 206 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 1111 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2022 | 1010 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2019 | 128 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 452 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 233 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2019 | 189 | 0.040 |
Why?
|
| Drug Stability | 1 | 2018 | 127 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 239 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2000 | 884 | 0.030 |
Why?
|
| Annexin A5 | 1 | 2017 | 27 | 0.030 |
Why?
|
| Ketoconazole | 1 | 2017 | 8 | 0.030 |
Why?
|
| Endocytosis | 2 | 2012 | 117 | 0.030 |
Why?
|
| Fluconazole | 1 | 2017 | 41 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2017 | 59 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2017 | 88 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 557 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2017 | 134 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2017 | 462 | 0.030 |
Why?
|
| Proteomics | 1 | 2018 | 363 | 0.030 |
Why?
|
| Cattle | 1 | 2017 | 505 | 0.030 |
Why?
|
| Heme | 1 | 2015 | 72 | 0.030 |
Why?
|
| Fibrosis | 1 | 2016 | 166 | 0.030 |
Why?
|
| Models, Biological | 1 | 2018 | 710 | 0.030 |
Why?
|
| Itraconazole | 1 | 2014 | 13 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 728 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2014 | 166 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 448 | 0.030 |
Why?
|
| Virion | 1 | 2014 | 73 | 0.030 |
Why?
|
| Cell Separation | 1 | 2014 | 94 | 0.030 |
Why?
|
| Cholesterol | 1 | 2014 | 230 | 0.020 |
Why?
|
| Tropical Medicine | 1 | 2012 | 10 | 0.020 |
Why?
|
| Clathrin | 1 | 2012 | 21 | 0.020 |
Why?
|
| RNA | 1 | 2014 | 266 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 411 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 518 | 0.020 |
Why?
|
| Life Cycle Stages | 1 | 2012 | 30 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2012 | 106 | 0.020 |
Why?
|
| Metabolome | 1 | 2012 | 50 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 661 | 0.020 |
Why?
|
| Mitochondria | 1 | 2015 | 516 | 0.020 |
Why?
|
| Skin | 1 | 2012 | 185 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 660 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 522 | 0.020 |
Why?
|
| Neoplasms | 1 | 2021 | 1341 | 0.020 |
Why?
|
| Biocatalysis | 1 | 2009 | 30 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2010 | 185 | 0.020 |
Why?
|
| Antiparasitic Agents | 1 | 2009 | 10 | 0.020 |
Why?
|
| Receptors, Fibronectin | 1 | 1989 | 3 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2009 | 36 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2009 | 37 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2012 | 461 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1989 | 116 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 1989 | 70 | 0.020 |
Why?
|
| alpha Karyopherins | 1 | 2008 | 3 | 0.020 |
Why?
|
| beta Karyopherins | 1 | 2008 | 4 | 0.020 |
Why?
|
| Hydroquinones | 1 | 2008 | 10 | 0.020 |
Why?
|
| K562 Cells | 1 | 2008 | 32 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2008 | 94 | 0.020 |
Why?
|
| Peptides | 1 | 2008 | 357 | 0.010 |
Why?
|
| Tyrosine | 1 | 2003 | 119 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 314 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2002 | 100 | 0.010 |
Why?
|
| DNA | 1 | 2003 | 594 | 0.010 |
Why?
|